Loading
Life sciences · Review
European Journal of Medicinal Plants · September 7, 2026
A consensus or society position rather than new primary data.
This narrative review identifies curcumin, Aloe vera, chamomile, liquorice, myrtle, pomegranate, sage and sumac as the botanicals with the strongest evidence for topical use in minor recurrent aphthous stomatitis, with several agents reducing pain, ulcer dimensions or healing time. However, confidence is substantially limited by small single-centre trials, heterogeneous formulations and doses, variable plant identity, incomplete blinding, and lack of placebo controls and adequate powering. Botanical products are characterised as promising adjuncts for appropriately diagnosed recurrent aphthous stomatitis but should not substitute for investigation of persistent, atypical or systemically associated oral ulceration.
Narrative review. Literature on recurrent aphthous stomatitis and oral ulceration; emphasis on botanical and medicinal plant treatments. Intervention: Topical botanical preparations including curcumin (Curcuma longa), Aloe vera, chamomile, liquorice, myrtle, pomegranate, sage and sumac. Compared with: Conventional symptomatic therapy; active comparators in primary trials without non-inferiority margins specified.
Curcumin derived from Curcuma longa, Aloe vera preparations, chamomile, liquorice, myrtle, pomegranate, sage and sumac show the strongest evidence for topical botanical preparations in minor recurrent aphthous stomatitis Several agents across trials and systematic reviews reduce pain, ulcer dimensions or healing time Major limitations include small single-centre samples, variable plant identity and extraction methods, heterogeneous formulations and doses, short observation periods, incomplete blinding, and active-comparator designs without non-inferiority margins
Source does not report recurrence rates, adverse-event frequencies, or comparative data versus standard topical therapy
Clinicians should regard medicinal plants as formulation-specific therapeutic candidates rather than interchangeable remedies, and recognize their role as adjuncts only; persistent, atypical or systemically associated oral ulceration requires investigation and should not be delayed by botanical treatment trials.
A critical narrative review synthesising evidence on oral ulceration diagnosis and management, with emphasis on botanical treatments for recurrent aphthous stomatitis; identifies promising agents but acknowledges major methodological limitations across the primary literature.
As stated by the source record.
Clinicians should regard medicinal plants as formulation-specific therapeutic candidates rather than interchangeable remedies, and recognize their role as adjuncts only; persistent, atypical or systemically associated oral ulceration requires investigation and should not be delayed by botanical treatment trials.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Oral ulcers are a frequent clinical problem but represent a heterogeneous group of lesions rather than a single disease. Their management therefore begins with diagnosis: traumatic, infectious, immune-mediated, drug-associated, systemic and potentially malignant causes require different responses. Recurrent aphthous stomatitis is the principal focus of botanical treatment research because it is common, painful, self-limiting and often recurrent despite conventional symptomatic therapy. This critical narrative review integrates evidence on the clinical assessment of oral ulceration, the pathobiology and management of recurrent aphthous stomatitis, and the therapeutic potential of medicinal plants. Literature was selected from major open scholarly sources using combinations of terms for oral ulceration, recurrent aphthous stomatitis, medicinal plants, herbal medicine, phytochemicals, randomised trials, pain, ulcer size, healing and recurrence. The evidence is strongest for topical botanical preparations evaluated in minor recurrent aphthous stomatitis, particularly curcumin derived from Curcuma longa, Aloe vera preparations, chamomile, liquorice, myrtle, pomegranate, sage and sumac. Across trials and systematic reviews, several agents reduce pain, ulcer dimensions or healing time, but confidence is constrained by small single-centre samples, variable plant identity and extraction methods, heterogeneous formulations and doses, short observation periods, incomplete blinding, active-comparator designs without non-inferiority margins, and the naturally resolving course of minor ulcers. Mechanistic plausibility based on anti-inflammatory, antioxidant, analgesic, antimicrobial and wound-healing actions is supportive but cannot substitute for clinical evidence. Botanical products should therefore be considered formulation-specific therapeutic candidates rather than interchangeable plant remedies. Progress requires authenticated plant material, chemically characterised preparations, placebo-controlled and adequately powered trials, recurrence-focused outcomes, rigorous adverse-event monitoring and direct comparisons with accepted topical therapy. Medicinal plants are promising adjuncts for appropriately diagnosed recurrent aphthous stomatitis, but they should not delay investigation of persistent, atypical or systemically associated oral ulceration.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.